Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) released its earnings results on Friday. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09, Zacks reports. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.The company had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 1.0%

Shionogi & Co., Ltd. Unsponsored ADR stock traded up $0.10 during trading hours on Friday, reaching $10.22. 50,568 shares of the company’s stock traded hands, compared to its average volume of 143,744. The firm’s 50 day moving average is $9.01 and its 200-day moving average is $8.72. Shionogi & Co., Ltd. Unsponsored ADR has a fifty-two week low of $6.74 and a fifty-two week high of $10.30. The firm has a market capitalization of $17.39 billion, a price-to-earnings ratio of 15.97, a PEG ratio of 2.10 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.